JJDC
Venture capitalNew Brunswick · Seed–Series B · 11 people tracked
Investment thesis
JJDC is the venture capital arm of Johnson & Johnson, investing since 1973 across medical devices, diagnostics, pharmaceuticals, and consumer health. The firm provides seed through late-stage venture financing to companies whose technologies and business models align with Johnson & Johnson's strategic interests.
Team · 11 people
from public directoriesWhat they invest in
from 5 of 5 portfolio companiesHealthtech ×4Biotech ×2AI & Machine Learning ×1Data & Infrastructure ×1Deep Tech ×1Digital Health ×1Medical Devices ×1Robotics ×1
HQs:United States×3
Investments · 5 tracked
founders shown can be your intro pathBy year:2025 · 12017 · 12015 · 13 dated
Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.
BiotechHealthtechMilpitas, US
Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)
BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)
Co-investorsAisling CapitalCanaan PartnersLilly VenturesStarfish Ventures
Data & InfrastructureDigital HealthHealthtechNew York, US
Sebastian G. Schneeweiss(Director)William Geary(Director)inJeremy Rassen(Executive Officer, Director)
Co-investorsB Capital GroupB4 CapitalBlue Lion GlobalFlare Capital PartnersForesite CapitalLG Technology Ventures+4 more
Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.
AI & Machine LearningBiotechDeep Tech
Co-investorsM VenturesOxford Science EnterprisesPfizer Venture InvestmentsBritish Patient CapitalPfizer Ventures
HealthtechCambridge, US
Adam Rosenberg(Executive Officer, Director)
BoardBruce Booth(Director)Kees Been(Director)Samantha Singer(Director)
Co-investorsGV (Google Ventures)Hatteras Venture PartnersThird Point VenturesAtlas VentureRemeditex Ventures
Ronovo Surgical develops the Carina surgical robotics platform, including a vision system and instruments, for use by surgeons and hospitals.
HealthtechMedical DevicesRobotics
Co-investorsGranite AsiaINCE CapitalVivo CapitalLilly Asia Ventures
Exits · 1
IPOs and acquisitions across the tracked portfolioProtagonist TherapeuticsNASDAQ: PTGX
Portfolio news
latest coverage across their companiesProtagonist Therapeutics · sahmcapital.com · Aug 6, 2026
Ronovo Surgical · fiercebiotech.com · Sep 9, 2025
Frequently asked questions
- What stage does JJDC invest at?
- JJDC invests at the Seed, Series A, Series B stages.
- What is JJDC's typical check size?
- JJDC typically writes checks of $500K – $5M.
- What sectors does JJDC focus on?
- JJDC focuses on Biotech, Consumer, Healthtech, Medical Devices.
- Where is JJDC located?
- JJDC is headquartered in New Brunswick, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Khosla Ventures is a venture capital firm that invests in early-stage companies focused on technology, mobile, and clean energy sectors, including biotechnology applications. The firm provides capital and strategic support to entrepreneurs developing breakthrough technologies across multiple markets.